Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amit Gupta

Vascular & Interventional Radiology Columbus, OH Medical Doctor

NPI 1740599331 CMS profile 954035

395 W 12Th Ave Rm 460, Ste 2120, Columbus, OH 43210

Open in the dashboard

General payments

$8,044

122 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$83,674 paid to institutions, not to them · program year 2024

Through program year 2025, Amit Gupta of Columbus, OH is reported in the CMS Open Payments database as having received $8,044 across 122 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $83,674 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 74th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $95 6
2024 General $141 9
2023 General $599 12
2022 General $389 19
2021 General $200 9
2020 General $1,098 35
2019 General $5,523 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amit Gupta
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Amit Gupta were reported at $95. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Amit Gupta Vascular & Interventional Radiology median Middle half National median
2019 $5,523 $422 $125–$1,555 $163
2020 $1,098 $200 $68–$652 $114
2021 $200 $280 $99–$866 $132
2022 $389 $433 $137–$1,497 $149
2023 $599 $506 $152–$2,019 $160
2024 $141 $556 $175–$1,930 $164
2025 $95 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Siemens Medical Solutions USA, Inc. $4,476 2 payments
  2. Medtronic USA, Inc. $1,031 45 payments
  3. Terumo Medical Corporation $949 14 payments
  4. Medtronic, Inc. $514 33 payments
  5. Sirtex Medical Inc $340 6 payments
  6. Galvanize Therapeutics, Inc $187 2 payments
  7. Penumbra, Inc. $132 6 payments
  8. Surefire Medical, Inc. $110 3 payments
  9. Boston Scientific Corporation $88 2 payments
  10. Relievant Medsystems, Inc. $69 2 payments
  11. Other $148 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $5,013 7 payments
  2. Food and Beverage $2,931 114 payments
  3. Education $100 1 payment
Products named General payments · program years 2019–2025
  1. SOMATOM GO $4,476 2 payments
  2. Navicross $747 8 payments
  3. INTELLIS $693 32 payments
  4. SIR-Spheres Microspheres $340 6 payments
  5. KYPHON EXPRESS II KYPHOPAK TRAY $322 20 payments
  6. AZUR $221 3 payments
  7. ALIYA SYSTEM $187 2 payments
  8. MYSTIM $152 1 payment
  9. TRINAV INFUSION SYSTEM $110 3 payments
  10. GlideWire $100 1 payment
  11. Other $1,012 51 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$24,028

Medicare's payments for the services billed

Medicare patients

110

Average age 68

Services billed

327

47 women, 63 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 49%
Chronic kidney disease 45%
Cancer 43%
Diabetes 37%
Ischemic heart disease 37%
Depression 33%
Heart failure 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record